After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Drug Manufacturers – General industry segment, falling under the Healthcare sector. The current market capitalization of Johnson & Johnson is $398.27B. A total of 11.99 million shares were traded on the day, compared to an average of 9.05M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, JNJ has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Decker Robert J sold 6,999 shares of JNJ for 165.88 per share on Feb 25 ’25. After the transaction, the VP Corporate Controller now owns 21,001 company shares. In a previous transaction on Feb 25 ’25, Decker Robert J bought 6,999 shares at 165.88 per share.
Among the insiders who sold shares, Schmid Timothy disposed of 403 shares on Feb 18 ’25 at a per-share price of $156.15. This resulted in the EVP, WW Chair, MedTech holding 15,098 shares of JNJ after the transaction. In another insider transaction, Wolk Joseph J sold 13,015 shares at $153.89 per share on Feb 07 ’25. Company shares held by the Exec VP, CFO now total 0.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Johnson & Johnson pays an annual dividend of $4.96, resulting in a dividend yield of 3.00%, and it has a price to earnings (P/E) ratio of 28.53. JNJ’s most recent ex-dividend date was 3.43% when it declared a $1.24 quarterly dividend that was paid in cash on 2/18/2025. Previously, the company paid the dividend on 11/26/2024 with an ex-dividend date of 3.07%. The JNJ stock dividend was $1.24 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for JNJ in the last 3 months, the mean price target is $168.94 with high estimates of $190.00 and low estimates of $150.00. In terms of 52-week highs and lows, JNJ has a high of $168.85 and a low of $140.68.
As of this writing, JNJ has an earnings estimate of $2.64 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of $2.88 per share and a lower estimate of $2.51.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $29.70, while its Total Shareholder’s Equity was $74.02B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JNJ is Buy with a score of 3.82.
